Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma-Reference-Cited by-同舟云学术

Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma

Published:2019-06-12 Issue:9 Volume:8 Page:e1621677
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zhu Chen¹,Zou Cunyi¹,Guan Gefei¹,Guo Qing¹,Yan Zihao¹,Liu Tianqi¹,Shen Shuai¹,Xu Xiaoyan²,Chen Chen³,Lin Zhiguo⁴,Cheng Wen¹,Wu Anhua¹

Affiliation:

1. Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning, China

2. Department of Pathophysiology, College of Basic Medicine Science, China Medical University, Shenyang, Liaoning, China

3. The Research Center for Medical Genomics, Key Laboratory of Cell Biology, Ministry of Public Health, Key Laboratory of Medical Cell Biology, Ministry of Education, College of Basic Medical Science, China Medical University, Shenyang, Liaoning, China

4. Department of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1621677

Reference73 articles.

1. The epidemiology of glioma in adults: a "state of the science" review

2. The Microenvironmental Landscape of Brain Tumors